Permanente physicians practicing Permanente Medicine excel in state-of-the-art cardiac surgeries.
Washington Permanente Medical Group focuses on wellness in every decision the medical group makes.
The president and executive medical director of Washington Permanente Medical Group stressed distribution simulations and constant communications as key factors to efficient vaccine rollout.
Peter Barkett, MD, an internist with Washington Permanente Medical Group, examines the history of vaccines and how they are powerful tools to promote public health.
Paul Minardi, MD, president and executive medical director of Washington Permanente Medical Group, surveys the history of pandemics and finds that infectious disease outbreaks have driven transformation and innovation in public health.
David Grossman, MD, of Washington Permanente Medical Group, and Eric Larson, MD, of Kaiser Permanente Washington Health Research Institute, published a peer-reviewed viewpoint in JAMA about the potentially powerful implications of population genomics for the future of health care.
A study published in the New England Journal of Medicine, led by Lisa A. Jackson, MD, of Kaiser Permanente’s Washington Health Research Institute, reports on promising results in the phase 1 trial of an experimental COVID-19 vaccine.
In a recent article by The Wall Street Journal, Eric Larson, MD, a physician with Washington Permanente Medical Group and senior investigator for the Kaiser Permanente Washington Health Research Institute, is quoted about dementia prevention research published in a report commissioned by the Lancet medical journal.
Julia Bae, MD, has accepted the role of chief operations officer for Washington Permanente Medical Group.
As part of a growing partnership, Permanente physicians are working to provide world-class care for Special Olympics athletes across multiple specialties.